High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence?

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 273-286

  Obrenovitch, Tihomir P ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID;

BRAIN ISCHEMIA; CELL DEATH; CONFERENCE PAPER; DEPOLARIZATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; SYNAPSE;

EID: 0033398278     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08004.x     Document Type: Conference Paper

References (75)

1. 1. Olney, J.W. & O.L. Ho. 1970. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227: 609-611.
2. 2. Olney, J.W. 1981. Kainic acid and other excitotoxins: a comparative analysis. Adv. Biochem. Psychopharmacol. 27: 375-384.
3. 3. Todd, E.C.D. 1993. Domoic acid and amnesic shellfish poisoning: a review. J. Food Prot. 56: 69-83.
4. 4. Peng, Y.G., T.B. Taylor, R.E. Finch, R.C. Switzer & J.S. Ramsdell, 1994. Neuroexcitatory and neurotoxic actions of the amnesic shellfish poison, domoic acid. Neuroreport 5: 981-985.
5. 5. Benveniste, H., J. Drejer, A. Schousboe & N.H. Diemer. 1984. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43: 1369-1374.
6. 6. Rothman, S.M. 1984. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4: 1884-1891.
7. 7. Simon, R.P., J.H. Swan, T. Griffiths & B.S. Meldrum. 1984. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 266: 850-852.
8. 8. Obrenovitch, T.P. & J. Urenjak. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51: 39-87.
9. 9. Obrenovitch, T.P. & J. Urenjak. 1997. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? J. Neurotrauma 14: 677-698.
10. 10. Shimizu-Sasamata, M., P. Bosque-Hamilton, P.L. Huang, M.A. Moskowitz & E.H. Lo. 1998. Attenuated neurotransmitter release and spreading depression-like depolarizations after focal ischemia in mutant mice with disrupted type I nitric oxide synthase gene. J. Neurosci. 18: 9564-9571.
11. 11. Bullock, R., A. Zauner, J.J. Woodward, J. Myseros, S.C. Choi, J.D. Ward, A. Marmarou & H.F. Young. 1998. Factors affecting excitatory amino acid release following severe human head injury. J. Neurosurg. 89: 507-518.
12. 12. Olney, J.W. & T. De Gubareff. 1978. Glutamate neurotoxicity and Huntington's chorea. Nature 271: 557-559.
13. 13. Mangano, R.M. & R. Schwarcz. 1983. Chronic infusion of endogenous excitatory amino acids into rat striatum and hippocampus. Brain Res. Bull. 10: 47-51.
14. 14. Toth, E. & A. Lajtha. 1989. Motor effects of intracaudate injection of excitatory amino acids. Pharmacol. Biochem. Behav. 33: 175-179.
15. 15. Schwarcz, R., D. Scholz & J.T. Coyle. 1978. Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues. Neuropharmacology 17: 145-151.
16. 16. Obrenovitch, T.P., J. Urenjak & E. Zilkha. 1994. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br. J. Pharmacol. 113: 1295-1302.
17. 17. Obrenovitch, T.P., J. Urenjak & E. Zilkha. 1997. Effects of increased extracellular glutamate levels on the local field potential in the brain of anaesthetized rats. Br. J. Pharmacol. 122: 372-378.
18. 18. Wahl, F., T.P. Obrenovitch, A.M. Hardy, M. Plotkine, R. Boulu & L. Symon. 1994. Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium-dependency. J. Neurochem. 63: 1003-1011.
19. 19. Obrenovitch, T.P., E. Zilkha & J. Urenjak. 1995. Intracerebral microdialysis: electrophysiological evidence of a critical pitfall. J. Neurochem. 64: 1884-1888.
20. 20. Obrenovitch, T.P., J. Urenjak & E. Zilkha. 1996. Evidence disputing the link between seizure activity and high extracellular glutamate. J. Neurochem. 66: 2446-2454.
21. 21. Obrenovitch, T.P., E. Zilkha & J. Urenjak. 1998. Effect of pharmacological inhibition of glutamate-uptake on ischemia-induced glutamate efflux and anoxic depolarization latency. Naunyn-Schmiedeberg's Arch. Pharmacol. 357: 225-231.
22. 22. Obrenovitch, T.P. & E. Zilkha. 1995. High extracellular potassium, and not extracellular glutamate, is required for the propagation of spreading depression. J. Neurophysiol. 73: 2107-2114.
23. 23. Obrenovitch, T.P., E. Zilkha & J. Urenjak. 1996. Evidence against high extracellular glutamate promoting the elicitation of spreading depression by potassium. J. Cereb. Blood Flow Metab. 16: 923-931.
24. 24. Marrannes, R., R. Willems, E. De Prins & A. Wauquier. 1988. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 457: 226-240.
25. 25. Obrenovitch, T.P. & E. Zilkha. 1996. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. Br. J. Pharmacol. 117: 931-937.
26. 26. Lauritzen, M. 1994. Pathophysiology of the migraine aura: the spreading depression theory. Brain 117: 199-210.
27. 27. Kanner, B.I. & A. Bendahan. 1982. Binding order of substrates to the sodium and potassium ion coupled L-glutamic acid transporter from rat brain. Biochemistry 21: 6327-6300.
28. 28. Back, T., M.D. Ginsberg, W.D. Dietrich & B.D. Watson. 1996. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology. J. Cereb. Blood Flow Metab. 16: 202-213.
29. 29. Busch, E., M.L. Gyngel, M. Eis, M. Hoehn-Berlage & K.A. Hossmann. 1996. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. J. Cereb. Blood Flow Metab. 16: 1090-1099.
30. 30. Clements, J.D., R.A. Lester, G. Tong, C.E. Jahr & G.L. Westbrook. 1992. The time course of glutamate in the synaptic cleft. Science 258: 1498-1501.
31. 31. Glavinovic, M.I. & H.R. Rabie. 1998. Monte Carlo simulation of spontaneous miniature excitatory postsynaptic currents in rat hippocampal synapse in the presence and absence of desensitization. Naunyn-Schmiedeberg's Arch. Pharmacol. 435: 193-202.
32. 32. Timmerman, W. & B.H.C. Westerink. 1997. Brain microdialysis of GABA and glutamate: What does it signify? Synapse 27: 242-261.
33. 33. Westerink, B.H.C., H.M. Hofsteede, G. Damsma & J.B. De Vries. 1988. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 337: 373-378.
34. 34. Miele, M., M.G. Boutelle & M. Fillenz. 1996. The source of physiologically stimulated glutamate efflux from the striatum of conscious rats. J. Physiol. (Lond.) 497: 745-751.
35. 35. Westerink, B.H.C. 1995. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70: 103-124.
36. 36. Bradford, H.F. 1995. Glutamate, GABA and epilepsy. Prog. Neurobiol. 47: 656-659.
37. 37. Millan, M.H., T.P. Obrenovitch, G.S. Sarna, S.-Y. Lok, L. Symon & B.S. Meldrum. 1991. Changes in rat brain extracellular glutamate concentration during seizures induced by systemic picrotoxin or focal bicuculline injection: an in vivo dialysis study with on-line enzymatic detection. Epilepsy Res. 9: 86-91.
38. 38. Sanchez-Prieto, J., I. Herrero, M.T. Miras-Portuga & F. Mora. 1994. Unchanged exocytotic release of glutamic acid in cortex and neostriatum of the rat during aging. Brain Res. Bull. 33: 357-359.
39. +-channel inhibitors: an analysis of plasma membrane ion fluxes. J. Neurochem. 67: 389-397.
40. 40. Dawson, L.A. & C. Routledge. 1995. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats. Br. J. Pharmacol. 116: 3260-3264.
41. 41. Pei, Q., R.A. Leslie, D.G. Graham-Smith & T.S.C. Zetterström. 1995. 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration. Neuroreport 6: 716-720.
42. 42. Segovia, G., A. Porras & F. Mora. 1997. Effects of 4-aminopyridine on extracellular concentrations of glutamate in striatum of the freely moving rat. Neurochem. Res. 22: 1491-1497.
43. 43. Hertz, L. 1979. Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Prog. Neurobiol. 13: 277-323.
44. 44. Westergaard, N., U. Sonnewald & A. Schousboe. 1995. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev. Neurosci. 17: 203-211.
45. 45. Obrenovitch, T.P. & J. Urenjak. 1998. The glutamate-excitotoxicity hypothesis: use and abuse. In Pharmacology of Cerebral Ischemia. J. Krieglstein, Ed. Medpharm. Stuttgart. In press.
46. 46. Lada, M.W., T.W. Vickroy & R.T. Kennedy. 1998. Evidence for neuronal origin and metabotropic receptor-mediated regulation of extracellular glutamate and aspartate in rat striatum in vivo following electrical stimulation of the prefrontal cortex. J. Neurochem. 70: 617-625.
47. 47. You, Z.-B., T.M. Tzschentke, E. Brodin & R.A. Wise. 1998. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. I. Neurosci. 18: 6492-6500.
48. 48. Rossetti, Z.L., C. Marcangione & R.A. Wise. 1998. Increase of extracellular glutamate and expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation of the prefrontal cortex. J. Neurochem. 70: 1503-1512.
49. 49. Korf, J. 1996. Intracerebral trafficking of lactate in vivo during stress, exercise, electroconvulsive shock and ischemia as studied with microdialysis. Dev. Neurosci. 18: 405-414.
50. 50. Sokoloff, L. 1993. Sites and mechanisms of function-related changes in energy metabolism in the nervous system. Dev. Neurosci. 15: 194-206.
51. +-induced depolarisation in the rat striatum. J. Neurochem. 62: 2368-2374.
52. 52. Edwards, F.A. 1995. Anatomy and electrophysiology of fast central synapses lead to a structural model for long-term potentiation. Physiol. Rev. 75: 759-787.
53. 53. Rusakov, D.A., E. Harrison & M.G. Stewart. 1998. Synapses in hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: a quantitative ultrastructure analysis with discussion of physiological implications. Neuropharmacology 37: 513-521.
54. 54. Eliasof, S. & F. Werblin. 1993. Characterization of the glutamate transporter in retinal cones of the tiger salamander. J. Neurosci. 13: 402-411.
55. 55. Ikonomidou, C. & L. Turski. 1996. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab. Brain Dis. 11: 125-141.
56. 56. Okiyama. K., D.H. Smith, W.F. White, K. Richter & T.K. McIntosh. 1997. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat. J. Neurotrauma 14: 211-222.
57. 57. Huang, Z., P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman & M.A. Moskowitz. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885.
58. 58. Panahian, N., T. Yoshida, P.L. Huang, E.T. Hedley-Whyte, T. Dalkara, M.C. Fishman & M.A. Moskowitz. 1996. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience 72: 343-354.
59. 59. Lo, E.H., P. Bosque-Hamilton & W. Meng. 1998. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke 29: 830-836.
60. 60. Ames, A. III. 1992. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can. J. Physiol. Pharmacol. 70(Suppl.): S158-S164.
61. 61. Ames. A. III, K.I. Maynard & S. Kaplan. 1995. Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J. Cereb. Blood Flow Metab. 15: 433-439.
62. + channels: a rational and effective strategy against ischemic brain damage. Pharmacol. Rev. 48: 21-67.
63. 63. Bacher, A., J.Y. Kwon & M.H. Zornow. 1998. Effects of temperature on cerebral tissue oxygen tension, carbon dioxide tension, and pH during transient global ischemia in rabbits. Anesthesiology 88: 403-409.
64. 64. Hoffman. W.E., F.T. Charbel, L. Munoz & J.I. Ausman. 1998. Comparison of brain tissue metabolic changes during ischemia at 35 degrees and 18 degrees C. Surg. Neurol. 49: 85-88.
65. 2+ after exposure to glutamate receptor agonist. Exp. Brain Res. 73: 447-458.
66. 66. Yoon, K.W. 1995. Glutamate effect on synaptic transmission mediates neurotoxicity in dissociated rat hippocampal neurons. Brain Res. 669: 320-324.
67. 2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine. Mol. Pharmacol. 36: 525-531.
68. 68. Schramm, M., S. Eimerl & E. Costa. 1990. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-D-aspartate. Proc. Natl. Acad. Sci. USA 87: 1193-1197.
69. 69. Sucher, N.J., S.Z. Lei & S.A. Lipton. 1991. Calcium-channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 551: 297-302.
70. 70. Stuiver, B.T., B.R.T. Douma, R. Bakker, C. Nyakas & P.G.M. Luiten. 1996. In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection. Neurodegeneration 5: 153-159.
71. 71. Krieglstein, J. 1997. Excitotoxicity and neuroprotection. Eur. J. Pharm. Sci. 5: 181-187.
72. 72. Obrenovitch, T.P. 1995. The ischaemic penumbra: twenty years on. Cerebrovasc. Brain Metab. Rev. 7: 297-323.
73. 73. Wilson, J.X. 1997. Antioxidant defence of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75: 1149-1163.
74. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20: 464-470.
75. 75. Doriat, J.F., A. Cortey & J.L. Daval. 1998. Selective alterations in binding kinetic parameters and allosteric regulation of N-methyl-D-aspartate receptors after prolonged seizures in the developing rat brain. Pediatr. Res. 43: 415-420.